Atlas Trials

Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma

Clinical trial NCT05416073 · UNKNOWN

Trial details

NCT number
NCT05416073
Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatocellular CarcinomaTransarterial ChemoembolizationHepatic Arterial Infusion ChemotherapyPain
Start date
2022-06-22
Primary completion
2023-04-30
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.